Breaking News

Joe Kennedy III, the AMA president, and former NIH leaders speak at STAT Summit

October 17, 2025
theresa-g-avatar-small - light bg
Morning Rounds Writer and Reporter
Good morning. After four days in a row with out-of-town colleagues and friends, I'm suffering from a case of the post-Summit blues today. Luckily, I have the day off to fully wallow. Read on for the latest news, and I'll talk to you next week. 

politics

Trump makes a deal on IVF

The Trump administration has made a deal with fertility therapeutics company EMD Serono as part of a larger push to expand coverage and improve affordability of IVF and similar services, officials announced at the White House on Thursday. The company has pledged to offer direct-to-consumer sales of its IVF therapies and to participate in the TrumpRx purchasing platform in 2026.

Fertility treatments have been a unique focus of the administration. Trump campaigned on expanding access to IVF, calling for universal coverage even as some Republican-led states pursued laws that would impact the creation of embryos by defining life as beginning at conception. Yesterday's announcement also marks the third drugmaker to strike a deal with the president in recent weeks, following Pfizer and AstraZeneca. Read more from STAT's Daniel Payne and Lizzy Lawrence about the conditions of the deal and what it all means.


IRL

The news from day two of the STAT Summit

Here are some of the big takeaways from yesterday's lively sessions:

  • In a conversation with STAT's Chelsea Cirruzzo, American Medical Association President Bobby Mukkamala defended the restrained advocacy strategy that the country's largest professional medical organization has taken with the Trump administration, while playing up the alignment between federal health officials and the AMA on issues like prior authorization. Read more from me on his illuminating statements. 
  • A week after hiring former top FDA official Peter Marks, Eli Lilly's Chief Scientific Officer Dan Skovronsky told STAT's Matt Herper that while he understands the "revolving door" criticism, blocking officials who have served the public from joining industry would limit the potential for medical progress. Read more from STAT's Ed Silverman. 
  • The big takeaway from a panel of former NIH leaders? Despite the chaos and disruption of the past year, the worst may be yet to come. "It's been like living in a washing machine," Jeremy Berg told STAT's Anil Oza. Read more from STAT's O. Rose Broderick.
  • Joe Kennedy III has "great memories" of growing up with his uncle, health secretary Robert F. Kennedy Jr. But he also has "grave concerns about the safety and integrity of our health system," which moved him to condemn his uncle's leadership as health secretary. Read more from STAT's Sarah Todd about the conversation Kennedy had with STAT's own executive editor Rick Berke.
  • Even as many parts of new Medicaid work requirements remain unclear, states are beginning to feel the deadline pressure, three current and former state Medicaid directors told STAT's Tara Bannow. Work requirements are set to go live by Jan. 1, 2027 — "The next 14 months are going to go really quickly," said MassHealth Undersecretary Mike Levine. STAT's Isabella Cueto will have more on this later today.

mental health

New study shows LGBTQ+ youth mental health is getting worse

Young LGBTQ+ people are experiencing worse mental health symptoms, more exposure to conversion therapy, and less access to mental health care, according to an interim report from a longitudinal survey study by the Trevor Project. The report encapsulates data collected from more than 1,600 LGBTQ+ youth ages 13 to 24, who were surveyed every six months between late 2023 and early 2025. A few key findings:

  • From the start of the study to March 2025, the proportion of respondents who reported symptoms of anxiety rose from 57% to 68%. Those reporting depressive symptoms rose from 48% to 54%, while those experiencing suicidal ideation climbed from 41% to 47%. 
  • Physical harassment and threats because of sexual orientation or gender identity were consistent and common throughout the study period. About a third of respondents were harassed or threatened due to their sexual orientation, while two-fifths of trans and nonbinary respondents were targeted for their gender identity. 
  • The percentage of youth who wanted mental health care and were able to get it started at 80% of respondents, but decreased over time to 60%. Respondents cited barriers including costs and fears of not being taken seriously or being involuntarily hospitalized.
  • At the beginning of the study, 9% of the study population had been exposed to conversion therapy efforts. By March 2025, 15% had.


people

Two scientists taking virology into the future

Sydney Ramirez stands smiling in a white coat.

La Jolla Institute for Immunology 

I highly recommend spending some time with these profiles of two new Wunderkind honorees:

As a clinical and research fellow who had just completed a Ph.D. in coronavirus virology, Sydney Ramirez (above) realized days into the Covid pandemic that her expertise could help answer pressing questions about SARS-CoV-2. So she spent the next few weeks gathering data, often driving across San Diego to collect blood samples directly from patients herself. For safety, her daughter was sent to live hours away with Ramirez's parents. That early scramble led to one of the first papers on Covid, proving that the disease prompted an immune response. Read more from STAT contributor Allessandra DiCorato about how Ramirez balances her important scientific work with her life as a single mother. As she said to DiCorato: "There are definitely days where I feel like I'm doing one 'job' better than the other."

Rafael Michita is a trailblazer in a different arena of infectious disease: the study of maternal-fetal viral transmission. His research, beginning in 2021 during his postdoctoral work, is among the first to suggest that the thin filaments that connect infected cells to their neighbors may also provide a route for viruses to breach the placenta. At the time, the leader of Michita's lab hadn't even heard of tunneling nanotubes, but knew because of his dedication that he was onto something exciting. Read more from STAT contributor Justin Chen about how Michita went from the countryside of Brazil to one of the world's most advanced laboratories for studying Zika virus infections, to potentially starting a lab of his own soon.  


some shrinking numbers

American trust in health agencies is falling

Americans trust the CDC and the FDA less now than they did at the end of last year, largely due to declining confidence among Democrats, according to new poll results from the Axios/Ipsos American Health Index. Out of more than 1,000 respondents, 66% trusted the CDC last December. That dropped to 60% in June and 54% this month. When it comes to the FDA, trust declined similarly: 60% had confidence in the agency last December, declining to 52% now. 

Trust in federal leaders is similarly mixed. Nineteen percent of poll respondents felt that policies from President Trump and health secretary Robert F. Kennedy Jr. have made the country healthier, but 41% say they've made the country less healthy and 36% say there's been no impact. The results echo previous polling that found nearly 60% of people disapprove of Robert Kennedy's overall performance.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • FDA announces first nine recipients of priority drug review vouchers, STAT
  • How America got hooked on ultra-processed food, New York Times

  • Biotech leaders say uncertainty at FDA threatens drug development, STAT
  • Anti-trans policies aren't preventing genital mutilation — they're disrupting efforts to stop it, The 19th
  • First Opinion: The radical democratization of academic medicine, STAT

Thanks for reading! More next time,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments